1. National Cancer Peer Review Programme NUSG Meeting 6 December 2012

2. New Improvement Body (nIB) Will bring together several legacy organisations –NHS Institute –NHS Improvement –National Cancer Action Team –End of Life Care Programme –NHS Diabetes and Kidney –National Technology Adoption Centre Work programme will be based around priorities identified by the 5 Domain Directors Julian Hartley appointed as Interim Managing Director

3. Business Continuity Some programmes of work will transfer to the nIB Some programmes will close because the work is completed Some programmes will need to continue and a suitable host will need to be found for it i.e. National Cancer Peer Review Programme Some programmes will be discontinued We need to capture the learning from all the work we have done. We need to ensure that the learning is passed on to successor organisations

4. The Future of Peer Review At the ‘Star Chamber’ meeting for the nIB Positive support to retain the programme However it was felt that it didn’t fit with nIB Should be hosted by; –Medical Directorate of NHS CB –PHE –Regulator Discussion currently on-going Agreed it could be hosted by the nIB until a suitable host is found.

5. Transition Delivery Partner (TDP) Will be established to continue some of the work of existing programmes and to commence delivery on new areas of work TDP will exist for a period up to one year from April 2013 to March 2014 Work programme will emerge from the nIB Business Plan It is proposed that the National Cancer Peer Review Programme will initially form part of the TDP

6. Strategy Clinical Networks Strategic Clinical Networks, Single Operating Framework - November 2012 Held a number of stakeholder events Next stage to appoint network support teams Plan to publish additional document by the end of November 2012: The Way Forward: Operational Delivery Networks

7. The NHS CB has confirmed four initial SCN groupings, which will operate throughout the country: Cancer; Cardiovascular; Maternity and Children; Mental health, dementia and neurological conditions.

13. Developing the future Peer Review Programme Greater focus on Outcomes –Using Service Profiles Limited data available currently –Fewer Measures Some process measures will be required –Minimising the evidence required Operational Policy Annual Report Work Programme Greater Transparency of the reports –My Cancer Treatment 13

14. The 2012/2013 Peer Review Cycle How we will manage the position with networks? The self assessment cycle is completed The peer review round is half way through –November network should have completed the evidence upload –Take each network on a case by case basis –Try to maintain the NSSGs

15. The 2013/2014 Peer Review Cycle Waiting to see how things develop over the next two months Early thoughts include: –Suspending the network board measures –Try to maintain the principle of site specific groups –Need to maintain at all costs, regional clinical guidelines –Suspending less critical network group measures i.e. partnership group

16. The Peer Review Programme NCPR could be adapted, as appropriate, to provide the following key roles: Monitor and benchmark the performance of each SCN at a number of levels; –The governance and implementation of appropriate configuration by the individual network –The governance of provider organisation and commissioners –The suitability and equity of provider facilities –The quality and outcomes of the clinical teams within a network

17. The Peer Review Programme Validate the national configuration of service to optimise clinical expertise with efficiency and viability for best patient outcomes Provide quality reports to support commissioners and inform patient choice

18. The Peer Review Programme If peer review used the mix of; Self-Assessment, Internal Validation, External Validation and Peer Review Visits. Using a 3/4 year external verification cycle and risk targeted visits of 10-15% of the service Run a programme on approximately £3 million a year and cover: –Cancer, –Stroke, –Paediatric Diabetes, –Renal, –Cardiac –Liver.

19. The Peer Review Programme This would require slimming down of the measures for Cancer i.e. not covering some of the network topics e.g. Partnership groups, Rehabilitation.